Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 34.94
-0.32 (-0.91%)
Feb 11, 2026, 4:00 PM EST
Bright Eye Hospital Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,724 | 2,660 | 2,705 | 1,715 | 1,703 | 1,359 |
Other Revenue | 18.59 | 18.59 | 12.79 | 11.09 | 7.4 | 3.01 |
| 2,742 | 2,678 | 2,718 | 1,726 | 1,710 | 1,362 | |
Revenue Growth (YoY) | 2.00% | -1.46% | 57.50% | 0.91% | 25.54% | 14.21% |
Cost of Revenue | 1,652 | 1,561 | 1,424 | 927.51 | 903.36 | 775.29 |
Gross Profit | 1,090 | 1,117 | 1,294 | 798.13 | 806.66 | 586.83 |
Selling, General & Admin | 962.89 | 1,012 | 913.35 | 694.23 | 627.16 | 422.99 |
Research & Development | 11.23 | 8.02 | 11.03 | 6.64 | - | - |
Other Operating Expenses | 17.36 | 8.12 | 5.89 | 3.19 | 2.67 | -9.68 |
Operating Expenses | 993.81 | 1,028 | 933.65 | 705.65 | 629.83 | 415.57 |
Operating Income | 95.84 | 88.92 | 360.37 | 92.47 | 176.83 | 171.27 |
Interest Expense | -86.95 | -87.09 | -74.67 | -57.56 | -48.44 | -1.66 |
Interest & Investment Income | 3.61 | 8.54 | 95.35 | 29.54 | 13.75 | 3.91 |
Currency Exchange Gain (Loss) | -0.05 | -0.05 | -0.41 | -0.01 | - | - |
Other Non Operating Income (Expenses) | 5.44 | -7.17 | -31.69 | -13.59 | -5.87 | -9.03 |
EBT Excluding Unusual Items | 17.89 | 3.15 | 348.96 | 50.84 | 136.27 | 164.49 |
Impairment of Goodwill | -4.54 | -4.54 | - | -1.64 | -8.12 | -11.57 |
Gain (Loss) on Sale of Investments | -6.77 | -3.51 | 0.1 | - | - | - |
Gain (Loss) on Sale of Assets | -8.24 | -0.93 | 0.06 | 0.56 | 0.93 | 0.75 |
Asset Writedown | -0.07 | -1.46 | -0.47 | -0.47 | -0.5 | -0.74 |
Other Unusual Items | -18.13 | -18.73 | 13.58 | 9.94 | 10.33 | - |
Pretax Income | -19.87 | -26.02 | 362.23 | 59.23 | 138.9 | 152.92 |
Income Tax Expense | 74.21 | 66.81 | 84.23 | 38.66 | 45.01 | 43.99 |
Earnings From Continuing Operations | -94.09 | -92.83 | 278.01 | 20.57 | 93.89 | 108.93 |
Minority Interest in Earnings | -7.27 | -9.03 | -10.09 | - | - | - |
Net Income | -101.35 | -101.86 | 267.91 | 20.57 | 93.89 | 108.93 |
Net Income to Common | -101.35 | -101.86 | 267.91 | 20.57 | 93.89 | 108.93 |
Net Income Growth | - | - | 1202.56% | -78.09% | -13.81% | 122.06% |
Shares Outstanding (Basic) | 153 | 150 | 150 | 129 | 112 | 112 |
Shares Outstanding (Diluted) | 153 | 150 | 150 | 129 | 112 | 112 |
Shares Change (YoY) | 5.37% | 0.08% | 16.43% | 15.01% | -0.39% | 3.75% |
EPS (Basic) | -0.66 | -0.68 | 1.79 | 0.16 | 0.84 | 0.97 |
EPS (Diluted) | -0.66 | -0.68 | 1.79 | 0.16 | 0.84 | 0.97 |
EPS Growth | - | - | 1018.75% | -80.95% | -13.40% | 115.56% |
Free Cash Flow | 159.1 | -160.43 | -12.41 | -8.68 | 104.62 | 80.91 |
Free Cash Flow Per Share | 1.04 | -1.07 | -0.08 | -0.07 | 0.94 | 0.72 |
Dividend Per Share | - | - | 0.400 | 0.100 | - | - |
Dividend Growth | - | - | 300.00% | - | - | - |
Gross Margin | 39.74% | 41.70% | 47.61% | 46.25% | 47.17% | 43.08% |
Operating Margin | 3.50% | 3.32% | 13.26% | 5.36% | 10.34% | 12.57% |
Profit Margin | -3.70% | -3.80% | 9.86% | 1.19% | 5.49% | 8.00% |
Free Cash Flow Margin | 5.80% | -5.99% | -0.46% | -0.50% | 6.12% | 5.94% |
EBITDA | 237.34 | 208.87 | 451.57 | 162.32 | 232.68 | 221.17 |
EBITDA Margin | 8.65% | 7.80% | 16.61% | 9.41% | 13.61% | 16.24% |
D&A For EBITDA | 141.5 | 119.95 | 91.2 | 69.84 | 55.85 | 49.9 |
EBIT | 95.84 | 88.92 | 360.37 | 92.47 | 176.83 | 171.27 |
EBIT Margin | 3.50% | 3.32% | 13.26% | 5.36% | 10.34% | 12.57% |
Effective Tax Rate | - | - | 23.25% | 65.27% | 32.41% | 28.77% |
Revenue as Reported | 2,742 | 2,678 | 2,718 | 1,726 | 1,710 | - |
Advertising Expenses | - | 220.74 | 240.06 | 197.96 | 178.68 | 139.17 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.